Lunai Bioworks’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lunai Bioworks have?
Lunai Bioworks has 23,430,653 shares outstanding.
What happened to Lunai Bioworks’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lunai Bioworks?
Currently, no hedge funds are holding shares in LNAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lunai Bioworks
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.